Heterogeneous natural history of Addison's disease: mineralocorticoid deficiency may predominate
- PMID: 36398876
- PMCID: PMC9782445
- DOI: 10.1530/EC-22-0305
Heterogeneous natural history of Addison's disease: mineralocorticoid deficiency may predominate
Abstract
Autoimmune Addison's disease (AAD) is defined as primary adrenal insufficiency due to immune-mediated destruction of the adrenal cortex. This destruction of steroid-producing cells has historically been thought of as an irreversible process, with linear progression from an ACTH-driven compensated phase to overt adrenal insufficiency requiring lifelong glucocorticoid replacement. However, a growing body of evidence suggests that this process may be more heterogeneous than previously thought, with potential for complete or partial recovery of glucocorticoid secretion. Although patients with persistent mineralocorticoid deficiency despite preserved or recovered glucocorticoid function are anecdotally mentioned, few well-documented cases have been reported to date. We present three patients in the United Kingdom who further challenge the long-standing hypothesis that AAD is a progressive, irreversible disease process. We describe one patient with a 4-year history of mineralocorticoid-only Addison's disease, a patient with spontaneous recovery of adrenal function and one patient with clinical features of adrenal insufficiency despite significant residual cortisol function. All three patients show varying degrees of mineralocorticoid deficiency, suggesting that recovery of zona fasciculata function in the adrenal cortex may occur independently to that of the zona glomerulosa. We outline the current evidence for heterogeneity in the natural history of AAD and discuss possible mechanisms for the recovery of adrenal function.
Keywords: Addison’s disease; adrenal insufficiency; autoimmunity; cortisol; glucocorticoid; mineralocorticoid.
Conflict of interest statement
SHP has consulted for Apitope/Worg and received speaker fees from Merck and IBSA. All other authors have no conflict of interest to declare.
References
-
- Dawoodji A, Chen JL, Shepherd D, Dalin F, Tarlton A, Alimohammadi M, Penna-Martinez M, Meyer G, Mitchell AL, Gan EHet al.High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison’s disease patients. Journal of Immunology 20141932118–2126. (10.4049/JIMMUNOL.1400056) - DOI - PMC - PubMed
-
- Laureti S, Bellis de A, Muccitelli VI, Calcinaro F, Bizzarro A, Rossi R, Bellastella A, Santeusanio F, Falorni A. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison’s disease. Journal of Clinical Endocrinology and Metabolism 1998833507–3511. (10.1210/JCEM.83.10.5149) - DOI - PubMed
-
- Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith Bet al.Estimated risk for developing autoimmune Addison’s disease in patients with adrenal cortex autoantibodies. Journal of Clinical Endocrinology and Metabolism 2006911637–1645. (10.1210/JC.2005-0860) - DOI - PubMed